## Cover Letter

Allnex USA Inc. Product Stewardship & Regulatory Affairs 78 Rivergate Drive Wilton, CT 06897 October 17, 2013 U.S. Environmental Protection Agency Office of Pollution Prevention & Toxics Confidential Business Information Center (CBIC) EPA East Building, room 6428 1201 Constitution Avenue Washington, D.C. 20004-3302 Dear Sir/Madam: REFERENCE: PMN for TS-CR13P3 On behalf of Allnex USA Inc., I am re-submitting a premanufacturing notice under Section 5 of the Toxic Substances Control Act using eTSCA Client. A PMN for this substance was previously submitted on September 16, 2013 but was deemed incomplete requiring correction of the structural representation of the substance to show stereochemistry. The structural representation has been corrected. Allnex USA Inc. is currently conducting our internal SDS battery of toxicity tests. The following tests are currently in progress and are expected to be completed in November: Acute Oral Toxicity (OECD 423) Acute Dermal Toxicity (OECD 402) Acute Eye Irritation (OECD 405) Acute Dermal Irritation (OECD 404) Reverse Mutation Assay "Ames Test" (OECD 471) Final test reports will be forwarded to the EPA at the completion of these test studies. The PMN and fee identification number is TS-CR13P3. The PMN registration fee with the identifying TS-number was paid by credit card using Pay.Gov. If you have any questions, please contact me at (203) 834-0426. Page 1 SANITIZED SUBMISSION

### Regards,

Daniel Liebowitz Regulatory Compliance Manager, Americas

Page 2 SANITIZED SUBMISSION

### 74504140389 IRRX131017607214505 CR13P3

X X X X X

X Page 3 SANITIZED SUBMISSION

### X



## X Page 4 SANITIZED SUBMISSIONDaniel Liebowitz Regulatory Compliance Manager, Americas Allnex USA Inc. 78 Rivergate Drive Wilton CT 06897 daniel.liebowitz@allnex.com

Daniel Liebowitz Regulatory Compliance Manager, Americas Allnex USA Inc. 78 Rivergate Drive Wilton CT 06897 daniel.liebowitz@allnex.com 203-834-0426 

## X X

X X Page 5 SANITIZED SUBMISSION

## X

XXX 

## X XXX 

## X XXX 

## X See Attachment 001 (Sanitized Structure.pdf)

Sanitized Structure.pdf Page 6 SANITIZED SUBMISSIONNot Applicable

Not Applicable
Not Applicable
Page 7 SANITIZED SUBMISSIONPage 8 SANITIZED SUBMISSIONPage 9 SANITIZED SUBMISSIONXXX

XXX Heteropolycyclic diacrylate 

## X X
None Page 10 SANITIZED SUBMISSION

### XXX XXX 

## X

X Coating Resin XXX 

### X XXX 

### X XXX 

### X XXX XXX XXX XXX 

### X

Page 11 SANITIZED SUBMISSION

## X XXX XXX XXX 

## X XXX X

Process Chemistry: Isosorbide is reacted with acrylic acid in the presence of toluene, methanesulfonic acid(catalyst) and stabilizors. After the reaction is completed, the isosorbide diacrylate is purified by aqueous washes to remove the catalyst and stabilizors. Toluene is removed by vacuum distillation. XXX XXX XXX XXX XXX 

## X

Page 12 SANITIZED SUBMISSIONSee Attachment 002 (Sanitized Flow Diagram.pdf)

Sanitized Flow Diagram.pdf Page 13 SANITIZED SUBMISSIONDrum-off final product. Safety glasses, impermeable gloves, coveralls/local exhaust ventilation Liquid, 100% 2 1 8

Page 14 SANITIZED SUBMISSION1 0 kg/batch 0 kg/batch Off-site Incineration 0 kg/batch

Page 15 SANITIZED SUBMISSION

### XXX 

## X

See Attachment 003 (Sanitized Formulation Diagram.pdf)

Sanitized Formulation Diagram.pdf The formulation process takes place in a single vessel. The vessel is drained via gravity from a bottom valve. Equipment cleaning takes place once at the end of a campaign. Empty drums are removed for recycling by a drum reconditioner. There are no water discharges from formulation operations. Page 16 SANITIZED SUBMISSIONNone expected

XXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X XXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X XXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X XXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X

Page 17 SANITIZED SUBMISSION

### XXX 

## X

See Attachment 004 (Sanitized Application Flow Diagram.pdf)

Sanitized Application Flow Diagram.pdf There are no water discharges from this operation. See the attached process flow diagram.
Page 18 SANITIZED SUBMISSIONXXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X XXX XXX XXX XXX XXX XXX XXX

XXX XXX XXX XXX



### X X X
X X

Page 19 SANITIZED SUBMISSIONPage 20 SANITIZED SUBMISSION001 Santized Structural Representation Sanitized Structure.pdf Pt.I, Sec.B, 1e. 1 002 Santized Process Flow Diagram Sanitized Flow Diagram.pdf Pt.2, Sec.A, 1d. 1 003 Santized Formulation Process Flow Diagram Sanitized Formulation Diagram.pdf Pt.2, Sec.B, 1a. 1 004 Sanitized Application Diagram Sanitized Application Flow Diagram.pdf Pt.2, Sec.B, 1a. (#2) 1 005 IRR 781 US SDS IRR 781 US SDS.pdf 8

Page 21 SANITIZED SUBMISSION

## X Measured <1 Estimate 20 1.1 Estimate Negligible Estimate ~50 Measured >100 Estimate

Page 22 SANITIZED SUBMISSION

## ATTACHMENT HEADER SHEET Attachment Number 001 Attachment Name Santized Structural Representation 

## Associated PMN Section Number

Pt.I, Sec.B, 1e. Does not contain CBI 

## Report Number IRRX131017607214505

## ATTACHMENT HEADER SHEET Attachment Number 002 Attachment Name Santized Process Flow Diagram 

## Associated PMN Section Number

Pt.2, Sec.A, 1d. Does not contain CBI 

## Report Number IRRX131017607214505

## ATTACHMENT HEADER SHEET Attachment Number 003 Attachment Name Santized Formulation Process Flow Diagram 

## Associated PMN Section Number

Pt.2, Sec.B, 1a. Does not contain CBI 

## Report Number IRRX131017607214505

## ATTACHMENT HEADER SHEET Attachment Number 004 Attachment Name Sanitized Application Diagram 

## Associated PMN Section Number

Pt.2, Sec.B, 1a. (#2) Does not contain CBI 

## Report Number IRRX131017607214505

## ATTACHMENT HEADER SHEET Attachment Number 005 Attachment Name IRR 781 US SDS 

## Associated PMN Section Number

N/A Does not contain CBI 

## Report Number IRRX131017607214505